Work

Abstract PS2-12-07: Metabolic and immune reprogramming via SCD1 inhibition enhances chemo-immunotherapy response in TNBC

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-12-07

Authors: P. P. Advani, S. K. Deshmukh, R. Whetten, M. Redig, M. Pawlush, S. Wu, J. Xiu, J. P. Leone, S. Gandhi, M. Lustberg, G. Sledge, J. Copland

Institutions: Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida), Caris Life Sciences (United States), Dana-Farber Cancer Institute, Emory University, Yale University

Language: English

Topic: Cancer, Lipids, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129212321

Cites:

Cited by: 1

Related to: